SCHEMBL5450185

SCHEMBL5450185

CNC(=O)COC(=O)N1CCC(CCc2ccc(C(F)(F)F)cc2)CC1

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FAAH O00519 1/20 0.77
MAOB P27338 1/20 0.49
ENPP2 Q13822 3/20 0.46
P2RX3 P56373 1/20 0.44
YAP1 P46937 1/20 0.42
GRIN2B Q13224 1/20 0.42
TEAD1 P28347 1/20 0.40
SLC2A1 P11166 1/20 0.39
TGFBR1 P36897 1/20 0.39
CYP11B1 P15538 1/20 0.39
CYP11B2 P19099 1/20 0.39
KDM4E B2RXH2 1/20 0.39
ALDH1A1 P00352 1/20 0.39
HRH3 Q9Y5N1 1/20 0.39
HPGD P15428 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
CHRM2 P08172 1/20 0.39
CHRM5 P08912 1/20 0.39
CHRM1 P11229 1/20 0.39
CHRM3 P20309 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5453583 0.94 FAAH (0.67) FAAHMAOBENPP2P2RX3YAP1
SCHEMBL5451896 0.88 FAAH (0.65) FAAHMAOBTEAD1ALDH1A1SMN1; SMN2
SCHEMBL5451937 0.87 FAAH (1.00) FAAHMAOBENPP2P2RX3KDM4E
SCHEMBL5451889 0.82 FAAH (0.57) FAAHMAOBENPP2TEAD1ALDH1A1
SCHEMBL2463086 0.81 FAAH (0.52) FAAHYAP1CYP11B1CYP11B2ALDH1A1
SCHEMBL5453621 0.81 FAAH (0.70) FAAHMAOBYAP1GRIN2BKDM4E
SCHEMBL4308368 0.81 HRH3 (0.53) FAAHENPP2HRH3
SCHEMBL20015404 0.81 MAOB (0.54) FAAHMAOBTGFBR1KDM4E
SCHEMBL5447729 0.80 FAAH (0.88) FAAHMAOBENPP2P2RX3KDM4E
SCHEMBL5454086 0.79 FAAH (0.77) FAAHENPP2GRIN2BSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070021405-A1 ARYL- AND HETEROARYLPIPERIDINECARBOXYLATE-DERIVATIVES METHODS FOR THEIR PREPARATION AND USE THEREOF AS FATTY ACID AMIDO HYDROLASE ENZYME INHIBITORS SANOFI-AVENTIS (FR) 2007-01-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070021405-A1 ARYL- AND HETEROARYLPIPERIDINECARBOXYLATE-DERIVATIVES METHODS FOR THEIR PREPARATION AND USE THEREOF AS FATTY ACID AMIDO HYDROLASE ENZYME INHIBITORS FAAH, FAAH2, HRH2 FAAH 1/4885MAOB 265/4885ENPP2 14/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.